Annemieke was invited to give a presentation on DCRT's oligonucleotide therapy at the first meeting of the AGORA consortium in London on 22 September. AGORA focuses on access to treatment for children with ultra-rare diseases which mainly include inborn errors of immunity or metabolism.
posted on October 6, 2022
Let us know your questions or suggestions